ZA878815B - Pasteurization of immunoglobulin solutions - Google Patents

Pasteurization of immunoglobulin solutions

Info

Publication number
ZA878815B
ZA878815B ZA878815A ZA878815A ZA878815B ZA 878815 B ZA878815 B ZA 878815B ZA 878815 A ZA878815 A ZA 878815A ZA 878815 A ZA878815 A ZA 878815A ZA 878815 B ZA878815 B ZA 878815B
Authority
ZA
South Africa
Prior art keywords
pasteurization
immunoglobulin solutions
mildly
immunoglobulin
solutions
Prior art date
Application number
ZA878815A
Other languages
English (en)
Inventor
A. Magnin Anthony
Wah Po-Shing
Dennis Paul
Original Assignee
Connaught Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Laboratories Limited filed Critical Connaught Laboratories Limited
Publication of ZA878815B publication Critical patent/ZA878815B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/861—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgG3, IgG4, IgA, or IgY

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA878815A 1986-11-25 1987-11-24 Pasteurization of immunoglobulin solutions ZA878815B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868628104A GB8628104D0 (en) 1986-11-25 1986-11-25 Pasteurization of immunoglobin solutions

Publications (1)

Publication Number Publication Date
ZA878815B true ZA878815B (en) 1988-05-24

Family

ID=10607869

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA878815A ZA878815B (en) 1986-11-25 1987-11-24 Pasteurization of immunoglobulin solutions

Country Status (16)

Country Link
US (1) US4849508A (xx)
EP (1) EP0269405B1 (xx)
JP (1) JPS6485929A (xx)
KR (1) KR900006889B1 (xx)
CN (1) CN1020253C (xx)
AT (1) ATE79276T1 (xx)
AU (1) AU596714B2 (xx)
BR (1) BR8706374A (xx)
CA (1) CA1302884C (xx)
DE (1) DE3781104T2 (xx)
ES (1) ES2033880T3 (xx)
GB (1) GB8628104D0 (xx)
GR (1) GR3005451T3 (xx)
MX (1) MX168854B (xx)
RU (1) RU2008916C1 (xx)
ZA (1) ZA878815B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165467A (en) * 1991-07-20 2000-12-26 Yoshihide Hagiwara Stabilized human monoclonal antibody preparation
JPH07126182A (ja) * 1993-10-27 1995-05-16 Green Cross Corp:The 組換えヒト血清アルブミン製剤の滅菌方法
FI952196A0 (fi) * 1995-05-08 1995-05-08 Suomen Punainen Risti Veripalv Framstaellning av immunoglobulin
US6686191B1 (en) * 1995-09-22 2004-02-03 Bayer Healthcare Llc Preparation of virally inactivated intravenously injectable immune serum globulin
CA2261291A1 (en) * 1996-07-18 1998-01-29 Csl Limited Pasteurization of immunoglobulin solutions
TW491855B (en) * 1996-08-07 2002-06-21 Csl Ltd Purification of immunoglobulins
CN1137727C (zh) * 1998-06-25 2004-02-11 四川远大蜀阳药业有限公司 无保护剂双重病毒灭活制备静注免疫球蛋白工艺
CN101810854A (zh) 1999-02-22 2010-08-25 巴克斯特国际公司 新的无白蛋白的因子viii制剂
AU2001234644A1 (en) * 2000-01-31 2001-08-07 Consortium For Plasma Science, Llc Methods for inactivating viruses
US8119138B2 (en) * 2000-05-10 2012-02-21 Signe Biopharma Inc. Anti-estrogen and immune modulator combinations for treating breast cancer
US7947275B2 (en) * 2000-05-10 2011-05-24 Signe Biopharma, Inc. Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
US7863011B2 (en) * 2000-05-10 2011-01-04 Signe Biopharma, Inc. Screening method for predicting susceptibility to breast cancer
GB0113179D0 (en) 2001-05-31 2001-07-25 Novartis Ag Organic compounds
EP1532983A1 (en) 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulin preparations having increased stability
US20060051347A1 (en) 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
US20080311078A1 (en) 2005-06-14 2008-12-18 Gokarn Yatin R Self-Buffering Protein Formulations
EP2076287A2 (en) * 2006-10-12 2009-07-08 Wyeth Methods and compositions with reduced opalescence
EP2249661B1 (en) * 2008-01-22 2018-05-16 Multimerics APS Products and methods to prevent infection
JP5779780B2 (ja) 2008-11-07 2015-09-16 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 第ｖｉｉｉ因子製剤
EP2531218B1 (en) 2010-02-04 2018-12-12 CSL Behring AG Immunoglobulin preparation
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
MX2019004580A (es) 2016-10-21 2019-08-12 Amgen Inc Formulaciones farmaceuticas y metodos para prepararlas.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3930039A (en) * 1971-07-30 1975-12-30 Molkerei J A Meggle Milchindus Method of preparing a protein concentrate from whey
US3896241A (en) * 1971-09-01 1975-07-22 Coca Cola Co Preparation of a whey protein concentrate
US3986927A (en) * 1975-04-28 1976-10-19 Armour Pharmaceutical Company Process for the purification and sterilization of acidophilic biologicals by extreme acidification at cold temperatures
DE2527064C3 (de) * 1975-06-18 1979-11-15 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines intravenösen Nativ-Human-Immunglobulin-Präparates mit natürlicher Halbwertszeit und gegenüber dem Ausgangsmaterial unveränderten Antikörperaktivität
NL7708005A (nl) * 1976-07-22 1978-01-24 Monsanto Co Werkwijze voor de bereiding van serumalbumine.
US4075197A (en) * 1976-09-20 1978-02-21 Monsanto Company Serum albumin production
CH630243A5 (fr) * 1978-05-11 1982-06-15 Nestle Sa Procede de recuperation des proteines du lactoserum.
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4623717A (en) * 1980-03-05 1986-11-18 Miles Laboratories, Inc. Pasteurized therapeutically active protein compositions
JPS57140724A (en) * 1981-02-25 1982-08-31 Green Cross Corp:The Heat-treatment of aqueous solution containing cold insoluble globulin
JPS5874617A (ja) * 1981-10-28 1983-05-06 Green Cross Corp:The 人由来血液凝固第７因子含有水溶液の加熱処理方法
DE3473407D1 (en) * 1983-05-02 1988-09-22 Immuno Ag Method of inactivating pathogens
JPH0669961B2 (ja) * 1984-09-25 1994-09-07 株式会社ミドリ十字 免疫グロブリンの加熱処理方法
JPH0825902B2 (ja) * 1985-02-21 1996-03-13 株式会社ミドリ十字 γ−グロブリンの加熱処理方法
DK595285D0 (da) * 1985-12-20 1985-12-20 Nordisk Gentofte Injicerbart og varmebehandet igg-praeparat og fremgangsmaade til fremstilling af samme
EP0445108A1 (en) * 1986-03-10 1991-09-11 RUBINSTEIN, Alan I. A method for treating gammaglobulin

Also Published As

Publication number Publication date
EP0269405A3 (en) 1989-05-10
KR900006889B1 (ko) 1990-09-24
DE3781104T2 (de) 1992-12-17
KR880005938A (ko) 1988-07-21
EP0269405A2 (en) 1988-06-01
MX168854B (es) 1993-06-11
AU8168187A (en) 1988-05-26
CN87101294A (zh) 1988-07-06
CA1302884C (en) 1992-06-09
GB8628104D0 (en) 1986-12-31
ES2033880T3 (es) 1993-04-01
AU596714B2 (en) 1990-05-10
BR8706374A (pt) 1988-07-19
JPS6485929A (en) 1989-03-30
JPH0438730B2 (xx) 1992-06-25
US4849508A (en) 1989-07-18
ATE79276T1 (de) 1992-08-15
RU2008916C1 (ru) 1994-03-15
CN1020253C (zh) 1993-04-14
EP0269405B1 (en) 1992-08-12
DE3781104D1 (de) 1992-09-17
GR3005451T3 (xx) 1993-05-24

Similar Documents

Publication Publication Date Title
GR3005451T3 (xx)
US4632980B1 (xx)
ATE71489T1 (de) Essbare dispersion.
GR3006561T3 (xx)
ES8704733A1 (es) Un metodo para tratar termicamente, inactivando virus, a una solucion acuosa de gamma-globulina
ATE84681T1 (de) Karrageenan enthaltendes waessriges gel.
AU587365B2 (en) Pasteurized human fibrinogen (HF), a process for its preparation and its use
ATE92337T1 (de) Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern.
EP0200157A3 (en) Use of an aqueous stabilized chlorite matrix solution in infectious conditions
ES2006632A6 (es) Procedimiento de tratamiento termico de fibrinogeno.
AU7408787A (en) A process for the preparation of a pasteurized immunoglobulin preparation
Özsoylu Bleeding Time in Atypical von Willebrand’s Disease